A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/195 (2006.01) A61K 9/22 (2006.01) A61P 25/02 (2006.01) A61P 25/06 (2006.01) A61P 25/08 (2006.01) A61P 25/14 (2006.01) A61P 25/18 (2006.01)
Patent
CA 2575555
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form. Further, an extended release oral dosage form for releasing gabapentin into the stomach, duodenum ans small intestine of the mammal, comprising a core comprising at least 800 mg of gabapentin, surrounded by a semipermeable membrane is described.
La présente invention a trait à un procédé de traitement pour l'épilepsie et d'autres états pathologiques, comprenant l'administration de la gabapentine en une forme de dosage à rétention gastrique. L'invention a également trait à une forme de dosage orale à libération prolongée pour la libération de la gabapentine dans l'estomac, le duodénum et l'intestin grêle du mammifère, comportant un noyau comprenant au moins 800 mg de gabapentine, enrobé d'une membrane semi-perméable.
Berner Bret
Gusler Gloria M.
Hou Sui Yuen Eddie
Depomed Inc.
Gowling Lafleur Henderson Llp
LandOfFree
A gastric retained dosage form of gabapentin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A gastric retained dosage form of gabapentin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A gastric retained dosage form of gabapentin will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1957621